Experimental MERS treatments enter clinical trial
Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies designed to treat people infected with Middle East respiratory syndrome coronavirus. The trial is sponsored by the NIAID, and is funded in part by the BRADA. May 18, 2018